EGFR and breast cancer: Besides, novel G protein-coupled estrogen receptor (GPR30) signaling pathway was inactivated by baicalein and decreased phosphorylation of Akt and ERK as well as tyrosine phosphorylation of epidermal growth factor receptor (EGFR) in breast cancer cells, leading to suppression of migration and invasion of cancer (105).